Chinese Online Healthcare Platform Joins $35M Series B Round Of Singaporean Start-Up

Login to View

Biofourmis, a Singapore-based start-up that uses digital therapeutics for the treatment of chronic conditions, announced on Wednesday that it has closed US$35 million in a series B round of financing from investors including Chinese online healthcare platform Jianke.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now


Already have an account or paid subscription? Log in


RELATED NEWS